Financial Gravity Asset Management, Inc. Halozyme Therapeutics, Inc. Transaction History

Financial Gravity Asset Management, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 15, 2023	SELL	$40.06 - $59.44 $21,752 - $32,275	-543 Reduced 90.5%	57 $842,000
Q3 2022 Nov 03, 2022	BUY	$38.53 - $51.78 $23,118 - $31,068	600 New	600 $2.22 Million
Q3 2021 Nov 12, 2021	SELL	$38.47 - $46.42 $2,808 - $3,388	-73 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$38.84 - $51.31 $271 - $359	7 Added 10.61%	73 $45,000
Q1 2021 May 17, 2021	BUY	$39.51 - $51.45 $2,607 - $3,395	66 New	66 $2.77 Million

543

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.62B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Financial Gravity Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Financial Gravity Asset Management, Inc. with notifications on news.